Development of C57BL/6 ES cell technology for high thoughput use.
Development of C57BL/6 ES cell technology for high thoughput use.
批准号:
7285214
负责人:
KLAUS H KAESTNER
金额:
$66.0万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-07 至 2008-08-31
关键词:
129 MouseAccountingAllelesBenchmarkingBiologicalBiological AssayBone Morphogenetic ProteinsCell DensityCell LineCellsCharacteristicsChimera organismCompetenceConditionConditioned Culture MediaConsultationsCulture MediaCytogeneticsDataDevelopmentES Cell LineElectroporationEmbryoEvaluationExonsFibroblastsFluorescenceFrequenciesGene TargetingGenesGenetic RecombinationGerm LinesGoalsGrowthGrowth FactorInbred Strains MiceIndividualInjection of therapeutic agentMolecularMolecular ProfilingMonitorMorphologyMouse StrainsMusNaturePathway interactionsPatternPolymerase Chain ReactionProductionPublishingRangeRateRecombinantsResearch PersonnelResourcesSignal PathwayTestingTimeWorkantibiotic G 418baseblastocystcostcytokineembryonic stem cellhigh throughput screeningimprovedleukemia inhibitory factormalenovelnull mutationprogramsself-renewalstemstem cell technologytime usetransmission processvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) The C57BL/6 (B6) inbred strain of mice is the preferred strain of mouse geneticists, however, high throughput gene targeting/trapping has been possible to date only with 129 strain embryonic stem (ES) cells. 129 ES lines maintain self-renewal under a wide range of conditions even in absence of mouse embryonic fibroblast (MEF) feeders if supplied with Bone Morphogenetic Protein (BMP) and Leukemia Inhibitory Factor (LIF). In contrast, self-renewal of B6 ES cells is dependent on the presence of MEFs. In preliminary data, we have shown that 129-conditioned medium dramatically improves the growth characteristics of B6 ES cells. We will exploit this discovery to make B6 cells less dependent on feeder cells and, if possible completely feeder-cell independent. Importantly, our approaches make no prior assumption of the biological nature of the difference in growth characteristics between 129 and B6 cell lines. We will pursue our goals through five specific aims: In Aim 1, we will evaluate 18 male B6 ES-cell lines and 6 male albino B6 lines for cytogenetic stability, doubling time, and germ line transmission. In Aim 2, we will optimize the growth conditions for feeder-less growth of B6 ES-cell lines using both published additives as well as novel cytokines and/or growth factors. These new additives will be identified through expression profiling of 129 vs. the B6 ES lines, because conditioned medium from 129, but not B6 ES cells promotes growth and feeder-independence of B6 ES-cells. In Aim 3 we will utilize the optimized conditions of feeder-less growth of B6 ES-cells for a final assessment of gene targeting capability by targeting five genes in each cell line. In Aim 4, we will develop a novel cost-effective high throughput test that rapidly predicts germ line transmission of ES lines and with a high degree of accuracy. We will exploit expression profiling to identify a subset of 96 genes whose expression level is most indicative of self-renewal and germ line transmission. These genes will then be used to develop a qPCR-based screen to predict germ line transmission that is more rapid, accurate and less expensive than conventional cytogenetics. In Aim 5, we will use BAG recombineering and our optimize growth conditions to derive null mutations in 50 mouse genes as selected by the KOMP steering committee. In summary, in reponse to RFA-DA-06-009 we will develop high throughput gene targeting with B6 ES-cells and derive a novel molecular assay to cost-effectively and rapidly monitor B6 ES cell lines and their targeted derivatives for germ-line competence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of senescent beta cells in T1D and T2D
-
批准号:10583684
-
项目类别:
-
资助金额:$75.85万
-
财政年份:2022
-
负责人:KLAUS H KAESTNER
-
依托单位:
The role of senescent beta cells in T1D and T2D
-
批准号:10708994
-
项目类别:
-
资助金额:$72.13万
-
财政年份:2022
-
负责人:KLAUS H KAESTNER
-
依托单位:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
-
批准号:10434813
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2020
-
负责人:KLAUS H KAESTNER
-
依托单位:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
-
批准号:10217062
-
项目类别:
-
资助金额:$54.43万
-
财政年份:2020
-
负责人:KLAUS H KAESTNER
-
依托单位:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
-
批准号:10654627
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2020
-
负责人:KLAUS H KAESTNER
-
依托单位:
The Human Pancreas Analysis Program for Type 2 Diabetes
-
批准号:10252957
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2019
-
负责人:KLAUS H KAESTNER
-
依托单位:
The Human Pancreas Analysis Program for Type 2 Diabetes
-
批准号:10020973
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2019
-
负责人:KLAUS H KAESTNER
-
依托单位:
The Human Pancreas Analysis Program for Type 2 Diabetes
-
批准号:10675236
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2019
-
负责人:KLAUS H KAESTNER
-
依托单位:
The Human Pancreas Analysis Program for Type 2 Diabetes
-
批准号:10568985
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2019
-
负责人:KLAUS H KAESTNER
-
依托单位:
The Human Pancreas Analysis Program for Type 2 Diabetes
-
批准号:10261669
-
项目类别:
-
资助金额:$94.0万
-
财政年份:2019
-
负责人:KLAUS H KAESTNER
-
依托单位:
Regulatory cascades in gastrointestinal proliferation
-
批准号:9474868
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2017
-
负责人:KLAUS H KAESTNER
-
依托单位:
Regulatory cascades in gastrointestinal proliferation
-
批准号:10222654
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2017
-
负责人:KLAUS H KAESTNER
-
依托单位:
Innovative Genetic Approaches for Hepatic Repopulation
-
批准号:8886227
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2015
-
负责人:KLAUS H KAESTNER
-
依托单位:
Epigenomic Profiling of Normal and Diabetic Pancreatic Beta-Cells
-
批准号:8307957
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Epigenomic Profiling of Normal and Diabetic Pancreatic Beta-Cells
-
批准号:7906408
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Epigenomics of the regenerating and aging beta-cell
-
批准号:7993323
-
项目类别:
-
资助金额:$52.63万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Epigenomic Profiling of Normal and Diabetic Pancreatic Beta-Cells
-
批准号:8074910
-
项目类别:
-
资助金额:$58.08万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Transcriptional control of pancreatic development
-
批准号:7993185
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Genome Analyzer for the Institute of Diabetes, Obesity, and Metabolism
-
批准号:7792078
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
Regulation and function of the MEG3 locus in human beta-cells
-
批准号:8759299
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2010
-
负责人:KLAUS H KAESTNER
-
依托单位:
海外基金